e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Aetiology, diagnosis and outcomes in community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late-breaking abstract: The differences in clinical presentations between severe health care-associated pneumonia and severe community-acquired pneumonia: A single center experience
G. Hong, S. W. Um, W. J. Koh, G. Y. Suh, M. P. Chung, H. J. Kim, O. J. Kwon, K. M. Jeon (Seoul, Republic Of Korea)
Source:
Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Session:
Aetiology, diagnosis and outcomes in community-acquired pneumonia
Session type:
Thematic Poster Session
Number:
2457
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Hong, S. W. Um, W. J. Koh, G. Y. Suh, M. P. Chung, H. J. Kim, O. J. Kwon, K. M. Jeon (Seoul, Republic Of Korea). Late-breaking abstract: The differences in clinical presentations between severe health care-associated pneumonia and severe community-acquired pneumonia: A single center experience. Eur Respir J 2011; 38: Suppl. 55, 2457
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Severe community-acquired pneumonia in China: epidemiology and clinical practice
Source: International Congress 2019 – Chinese programme 2019: Part II
Year: 2019
Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality
Source: Eur Respir J 2011; 38: 253-260
Year: 2011
The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007
Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis
Source: Eur Respir J 2011; 37: 858-864
Year: 2011
Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice
Source: Milan 2017 - Educational material
Year: 2017
Defining community-acquired pneumonia severity on presentation to hospital: a derivation study
Source: Eur Respir J 2004; 24: Suppl. 48, 186s
Year: 2004
Aetiology and outcome of severe community-acquired pneumonia: overview of ICU cases on 1998
Source: Eur Respir J 2001; 18: Suppl. 33, 404s
Year: 2001
Comparison of the predictive performance of severity assessment tools in community-acquired or health care-associated pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
Community-acquired pneumonia in COVID-19 positive children: monitoring the clinical course
Source: Virtual Congress 2021 – Acute paediatric respiratory infections
Year: 2021
Severe community acquired pneumonia: clinical and aetiological evaluation
Source: Eur Respir J 2007; 30: Suppl. 51, 673s
Year: 2007
Healthcare-associated pneumonia among hospitalized patients. Is it really different from community acquired pneumonia?
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Health care associated pneumonia (HCAP) and community acquired pneumonia (CAP): Are they different diseases?
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
PATS and ERS paediatric webinar: reducing the burden of CAP
Source: ERS webinar 2021: PATS and ERS paediatric webinar: reducing the burden of CAP
Year: 2021
Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009
Another view on the prediction of outcomes in patients with community-acquired pneumonia
Source: Eur Respir J 2011; 38: 991-992
Year: 2011
Another view on the prediction of outcomes in patients with community-acquired pneumonia
Source: Eur Respir J 2011; 38: 992-993
Year: 2011
Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006
Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept